Volume | 47,000 |
|
|||||
News | - | ||||||
Day High | 0.0242 | Low High |
|||||
Day Low | 0.0221 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Costas Inc (PK) | CSSI | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0242 | 0.0221 | 0.0242 | 0.0221 | 0.03 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6 | 47,000 | $ 0.023698 | $ 1,114 | - | 0.0042 - 0.034 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:16:27 | 8,750 | $ 0.0221 | USD |
Costas Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8.91M | 445.73M | 90.22M | 173k | -1.65M | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Costas (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CSSI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0241 | 0.03 | 0.02 | 0.0270968 | 77,500 | -0.002 | -8.30% |
1 Month | 0.0243 | 0.034 | 0.02 | 0.0284317 | 48,475 | -0.0022 | -9.05% |
3 Months | 0.0323 | 0.034 | 0.014816 | 0.0284388 | 22,980 | -0.0102 | -31.58% |
6 Months | 0.018 | 0.034 | 0.0116 | 0.0250207 | 41,610 | 0.0041 | 22.78% |
1 Year | 0.00495 | 0.034 | 0.0042 | 0.017998 | 63,168 | 0.01715 | 346.46% |
3 Years | 0.0215 | 0.0788 | 0.00305 | 0.0219914 | 95,169 | 0.0006 | 2.79% |
5 Years | 0.088 | 0.16 | 0.003 | 0.0315207 | 70,834 | -0.0659 | -74.89% |
Costas (PK) Description
Costas, Inc. (CSSI) is a company engaged in discovering, acquiring, and developing dental labs throughout the United States. The Company plans to acquire independent labs looking to exit the market or who may be interested in retirement. Acquiring labs will be the focus of our growth strategy. Labs will be consolidated into one regionally central lab, and continue to operate, adding revenue to the company's income statement. All North American markets with populations over 1 million are targets. The company is headquartered in Orlando, Florida. |